ArTS Archivio della ricerca di Trieste

MARZARI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.015
EU - Europa 16.124
AS - Asia 15.068
SA - Sud America 5.002
AF - Africa 586
OC - Oceania 395
Continente sconosciuto - Info sul continente non disponibili 27
Totale 61.217
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.021
CN - Cina 5.480
IT - Italia 4.596
BR - Brasile 2.950
SG - Singapore 1.622
ES - Italia 1.577
DE - Germania 1.437
MX - Messico 1.278
GB - Regno Unito 1.181
JP - Giappone 1.157
IN - India 1.072
FR - Francia 1.058
TR - Turchia 1.007
SE - Svezia 785
ID - Indonesia 764
HK - Hong Kong 693
UA - Ucraina 693
VN - Vietnam 692
PL - Polonia 605
KR - Corea 564
NL - Olanda 511
CA - Canada 497
CO - Colombia 487
PT - Portogallo 464
AR - Argentina 446
TW - Taiwan 446
FI - Finlandia 413
PE - Perù 384
RU - Federazione Russa 378
CL - Cile 346
GR - Grecia 346
AU - Australia 329
AT - Austria 261
CH - Svizzera 256
TH - Thailandia 256
BE - Belgio 218
EC - Ecuador 217
RO - Romania 196
IE - Irlanda 186
SA - Arabia Saudita 177
DK - Danimarca 165
PK - Pakistan 154
EG - Egitto 144
IR - Iran 134
BG - Bulgaria 125
IL - Israele 110
CZ - Repubblica Ceca 102
MY - Malesia 98
HU - Ungheria 89
MA - Marocco 87
PH - Filippine 83
ZA - Sudafrica 81
HR - Croazia 73
SI - Slovenia 70
IQ - Iraq 66
RS - Serbia 66
NZ - Nuova Zelanda 62
VE - Venezuela 61
BD - Bangladesh 58
TN - Tunisia 56
NO - Norvegia 50
LB - Libano 49
LT - Lituania 49
LV - Lettonia 49
PA - Panama 44
JO - Giordania 42
UY - Uruguay 38
AE - Emirati Arabi Uniti 37
BO - Bolivia 37
CR - Costa Rica 37
KZ - Kazakistan 37
GT - Guatemala 36
SK - Slovacchia (Repubblica Slovacca) 34
DZ - Algeria 31
NG - Nigeria 31
PY - Paraguay 29
UZ - Uzbekistan 27
QA - Qatar 26
HN - Honduras 23
LK - Sri Lanka 23
PS - Palestinian Territory 23
NP - Nepal 22
SY - Repubblica araba siriana 21
KE - Kenya 20
BY - Bielorussia 19
CY - Cipro 18
DO - Repubblica Dominicana 18
ET - Etiopia 16
GE - Georgia 16
EU - Europa 15
OM - Oman 15
EE - Estonia 14
NI - Nicaragua 14
AZ - Azerbaigian 12
KW - Kuwait 12
LY - Libia 12
PR - Porto Rico 12
BA - Bosnia-Erzegovina 11
RE - Reunion 11
CD - Congo 10
Totale 60.970
Salva come PNG Salva come JPEG
Città #
Ashburn 8.901
Woodbridge 1.043
Ann Arbor 1.026
Germantown 1.013
Singapore 995
Houston 955
Fairfield 829
Milan 621
Beijing 600
Jacksonville 563
Rome 536
São Paulo 509
Chandler 494
San Jose 426
Madrid 408
Wilmington 408
Hong Kong 404
Seattle 385
Shanghai 355
Trieste 347
Guangzhou 346
Hefei 338
Seoul 316
Cambridge 309
Tokyo 302
Istanbul 301
Los Angeles 260
Dallas 259
Chicago 255
Lima 249
Barcelona 248
Rio de Janeiro 246
Paris 240
Ho Chi Minh City 230
Munich 219
Bogotá 211
Hangzhou 208
Frankfurt am Main 197
Princeton 197
Boardman 188
Hanoi 185
Athens 183
Santiago 181
Buenos Aires 179
Taipei 179
New York 178
Izmir 170
Jakarta 169
Lisbon 168
Dublin 166
Moscow 155
Warsaw 155
Vienna 154
Ankara 153
Helsinki 151
Naples 148
Chengdu 146
Turin 138
Bangkok 137
Bologna 134
Bengaluru 132
The Dalles 128
Amsterdam 126
Columbus 126
Florence 126
London 125
Nanjing 115
Curitiba 112
Brasília 110
Sofia 108
Berlin 104
Hyderabad 104
Medellín 104
Chennai 101
Melbourne 100
Mumbai 100
Valencia 98
Zurich 97
Las Vegas 94
Zgierz 93
Wuhan 92
Toronto 90
Copenhagen 89
Lauterbourg 89
Sydney 88
Verona 88
Guadalajara 87
Thessaloniki 87
Goiânia 86
Porto 86
Quito 86
Benito Juarez 85
Porto Alegre 85
Buffalo 83
Washington 83
Brussels 82
Belo Horizonte 80
Boston 80
Montreal 80
Shenzhen 77
Totale 33.072
Salva come PNG Salva come JPEG
Nome #
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 44.736
Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats. 309
Anti-transglutaminase antibodies and age. 297
Anti transglutaminase antibodies cause ataxia in mice. 291
A reliable screening procedure for coeliac disease in clinical practice. 289
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 286
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 272
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 251
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 249
Using archaeal histones for precise DNA fragmentation , 20: 267-271 (2007) 245
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 244
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 237
Autoantibodies as predictors of disease. 236
Comparison of multiple forms of the high mobility group I proteins in rodent and human cells. Identification of human high mobility group I-C protein 235
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 230
The gut as site of production of autoimmune antibodies. 228
Dual sugar gut-permeability testing on blood drop in animal models. 228
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 226
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 223
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 223
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab. 218
Anti-transglutaminase and age, Clinical Chemestry 217
Anti-idiotypic response in mice expressing human autoantibodies. 208
Anti tTG autoantibodies crossreacting with brain structures are produced in the intestine in celiac patient with equilibrium disorder 208
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 207
Anti-alpha enolase autoantibodies in coeliac disease 206
Antibodies against breain structures in a celiac patient with ataxic syndrome are produced in the intestine 203
Antibodies in proteomics I: generating antibodies 200
Development of a novel rapid non-invasive screening test for coeliac disease. 196
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 193
Gluten ataxia: passive transfer in a mouse model. 193
A zonulin-occludens toxin synthetic esapeptide modifies the intestinal permeabilità in in-vivo animal model 192
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. 191
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 191
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 190
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 188
"Recombinant antibodies against human type ii transglutaminase and uses thereof" 187
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 181
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 181
Protective role of anti-idiotypic network in celiac disease prone subjects 181
A method for selecting phage display open reading frames on phages 176
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 176
Profiling the Autoantibody Repertoire by Screening Phage-Displayed Human cDNA Libraries 176
Charecterization of tissue transglutaminase auto-antigenic response using cloned structural domains 174
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 170
Site of syntesis of antibodies to A-gliadin and tissue-transglutaminase in celiac disease patients 169
Antibodies anti-c5 component of the complement system and their use 168
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 168
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 168
Protective role of anti-idiotypic network in celiac disease prone subjects 167
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 166
Antibody library selection by the {beta}-lactamase protein fragment complementation assay 165
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal-mucosa anti-transglutaminase antibodies 164
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. 163
null 163
Rapid characterization of VH-5 family specific anti-tTG intestinal antibodies in celiac and autoimmune patients 162
A rat atlas to characterise anti brain humoral resoponse in patients with gluten sensitivity and celiac disease 160
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 158
Protective role of anti-idiotypic network in celiac disease prone subjects 155
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 155
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies 154
Characterizing monoclonal antibody epitopes by filtered gene fragment phagedisplay. 149
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 148
Phage display of Bacillus thuringiensis CryIA(a) insecticidal protein 147
Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet 146
J Pediatr Gastroenterol Nutr 1990 Oct;11(3):337-41 A dot immunobinding assay to detect anti-alpha-gliadin antibodies in celiac disease. 143
Patterning of fibronectin using laser writer for force measurement in cells 142
Profiling celiac disease antibody repertoire 142
Antibodies in proteomics 142
RECOMBINANT ANTIBODIES AGAINST CD55 AND CD59 AND USES THEREOF 141
Immunochemical characterisation of a murine monoclonal anti-idiotypic antibody 141
“Impianto di cellule epiteliali amniotiche umane crioconservate in un soggetto affetto da malattia di Niemann-Pick tipo B.” 139
Simple scale-up of recombinant antibody production using an UCOE containing vector 137
Serum immunoglobulin A and G, and monoclonal antibodies anti-tissue transglutaminase from coeliac patients inhibit the catalytic activity both in vitro and in situ 130
Small, antibacterial and large, inactive peptides of neutrophil granules share immunoreactivity to a monoclonal antibody. 129
Human monoclonal anti-transglutaminase antibodies from celiac patients inhibit cell induced apoptosis 126
Expression of a cloned Bacillus thuringiensis delta-endotoxin gene in Bacillus subtilis 125
Malattia celiaca: tra passato e futuro 122
null 119
Identification of new antigen candidate of Multiple Sclerosis using an ORF selected phage display library 118
Coeliac disease risk in patients with idiopathic dilated cardiomiopathy 114
Serum IgA and IgG and intestinal monoclonal anti-tissue transglutaminase antibodies from coeliac patients inhibit the catalytic activity both in vitro and in situ 111
Human tissue transglutaminase ELISA: a powerful mass screening diagnostic assay for symptomatic and asymptomatic celiac disease. 108
Correlation between anti-transglutaminase antibodies and healthy status in the general population 108
Intestinal mucosa anti-transglutaminase antibodies in early stage of gluten intolerance 107
Salivary anti-human transglutaminase in the diagnosis of coeliac disease 107
Filtering out open reading frames 106
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 103
Monoclonal anti-transglutaminase antibodies from celiac disease patients inhibit cell-induced apoptosis 102
null 100
Phage antibody library from celiac disease patient. 100
Identification of novel celiac disease autoantigens by combined phage display and protein array technology 99
Creation of a mouse model of coeliac disease by in vivo long term expression of disease specific anti trasnglutaminase antibody 99
null 97
Oral mucosa precedes the intestine on the gluten-dependent immune response 79
Rapid interactome profiling by massive sequencing 79
Selecting Open Reading Frames from DNA 69
Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies 66
Predicting antigenic peptides suitable for the selection of phage antibodies 64
Molecular dissection of the tissue transglutaminase antoantibody response in celiac disease 51
Totale 61.398
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021358 0 0 0 0 0 0 0 0 0 170 49 139
2021/20221.057 38 71 36 113 47 101 45 37 122 103 92 252
2022/20231.484 167 199 112 212 172 272 2 113 159 8 51 17
2023/2024770 50 61 41 76 83 70 114 145 8 7 56 59
2024/202520.332 15 60 152 166 256 215 136 103 274 178 5.855 12.922
2025/202630.357 5.562 4.932 5.587 5.172 4.919 2.253 653 186 593 500 0 0
Totale 61.398